| Line Item | 2024-01-31 | Y/Y |
|---|---|---|
| Revenue | $506.6M | +8.2% |
| Cost of Revenue | $476.5M | +24.7% |
| Gross Profit | $30.1M | -65.0% |
| R&D Expense | $220.8M | +13.2% |
| SG&A Expense | $109.1M | +20.7% |
| Operating Income | -$450.0M | -31.6% |
| Interest Expense | $16.3M | +72.5% |
| Pre-tax Income | -$457.6M | -31.8% |
| Income Tax | -$21K |
| Line Item | 2024-01-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $327.4M | +23.9% |
| Accounts Receivable | $124.0M | -24.8% |
| Inventory | $198.6M | +188.9% |
| Current Assets | $742.7M | +5.5% |
| Total Assets | $1.10B | +2.2% |
| Current Liabilities | $330.2M | +16.1% |
| Long-term Debt | $283.7M | -3.8% |
| Line Item | 2024-01-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$328.9M | -23.2% |
| Capital Expenditures | $19.4M | +4.6% |
| Investing Cash Flow | $85.6M | +167.8% |
| Financing Cash Flow | $306.5M | -17.8% |
| Free Cash Flow | -$348.4M | -22.0% |
| +99.0% |
| Net Income | -$457.6M | -32.6% |
| EPS (Basic) | -$1.22 | -19.6% |
| EPS (Diluted) | -$1.22 | -19.6% |
| Total Liabilities |
| $775.7M |
| +7.0% |
| Stockholders' Equity | $327.7M | -7.7% |